chr3-122284994-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM1PP2BP4
The NM_000388.4(CASR):c.3040C>T(p.Leu1014Phe) variant causes a missense change. The variant allele was found at a frequency of 0.00000372 in 1,614,112 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000388.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CASR | ENST00000639785.2 | c.3040C>T | p.Leu1014Phe | missense_variant | Exon 7 of 7 | 1 | NM_000388.4 | ENSP00000491584.2 | ||
CASR | ENST00000498619.4 | c.3070C>T | p.Leu1024Phe | missense_variant | Exon 7 of 7 | 1 | ENSP00000420194.1 | |||
CASR | ENST00000638421.1 | c.3040C>T | p.Leu1014Phe | missense_variant | Exon 7 of 7 | 5 | ENSP00000492190.1 | |||
CASR | ENST00000490131.7 | c.2809C>T | p.Leu937Phe | missense_variant | Exon 5 of 5 | 5 | ENSP00000418685.2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251412Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135904
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461880Hom.: 0 Cov.: 37 AF XY: 0.00000138 AC XY: 1AN XY: 727242
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152232Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74386
ClinVar
Submissions by phenotype
Autosomal dominant hypocalcemia 1 Uncertain:1
This CASR variant (rs202219108) is rare (<0.1%) in a large population dataset (gnomAD: 1/251412 total alleles; 0.0004%; no homozygotes) and has not been reported in the literature, to our knowledge. This variant has been reported in ClinVar (Variation #: 585622). Of three bioinformatics tools queried, two predict that the substitution would be damaging while one predicts that it would be tolerated. The leucine at this position is evolutionarily conserved across many of the species assessed. We consider the clinical significance of c.3040C>T to be uncertain at this time. -
Nephrolithiasis/nephrocalcinosis Uncertain:1
The p.L1014F variant (also known as c.3040C>T), located in coding exon 6 of the CASR gene, results from a C to T substitution at nucleotide position 3040. The leucine at codon 1014 is replaced by phenylalanine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
- -
Autosomal dominant hypocalcemia 1;C1809471:Familial hypocalciuric hypercalcemia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at